TI
RIGL icon

Trexquant Investment’s Rigel Pharmaceuticals RIGL Stock Holding History

Trexquant Investment’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.31M Sell
33,562
-182,848
-84% -$5.64M 0.01% 1368
2026
Q1 		$5.85M Buy
216,410
+19,262
+10% +$647K 0.04% 579
2025
Q4 		$8.44M Buy
197,148
+30,030
+18% +$1.13M 0.08% 372
2025
Q3 		$4.73M Buy
+167,118
New +$5M 0.05% 570
2025
Q2 		– Sell
-33,101
Closed -$595K – 1818
2025
Q1 		$595K Sell
33,101
-11,070
-25% -$225K 0.01% 1238
2024
Q4 		$743K Buy
+44,171
New +$847K 0.01% 1186

Other funds holding RIGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Trexquant Investment's RIGL Position: Q2 2026 in Review

Trexquant Investment reduced its Rigel Pharmaceuticals (RIGL) stake by 84% in Q2 2026, selling an estimated $5.64M and leaving 33,562 shares worth $1.31M. The position accounts for 0.01% of the portfolio, ranked #1368.

Trexquant Investment first reported a position in RIGL in Q4 2024 and has held it in 6 quarters since. The position peaked at $8.44M in Q4 2025. 156 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

  • Trexquant Investment held 33,562 shares of Rigel Pharmaceuticals worth $1.31M as of Q2 2026.
  • Trexquant Investment sold 182,848 Rigel Pharmaceuticals shares in Q2 2026, an estimated $5.64M.
  • Rigel Pharmaceuticals made up 0.01% of Trexquant Investment's portfolio in Q2 2026, its #1368 holding.
  • Trexquant Investment first reported a position in Rigel Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • Trexquant Investment's Rigel Pharmaceuticals position peaked at $8.44M in Q4 2025.
  • 156 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.